Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

March 31, 2019

Conditions
Infection Due to ESBL Escherichia Coli
Interventions
DRUG

Fosfomycin sodium intravenous

4g every 6 hours iv (60 min infusion)

DRUG

Meropenem intravenous

1g every 8 hours (15-30 min infusion) It depends on strain sensitivity: Strain with resistance to cephalosporins

DRUG

Ceftriaxone intravenous

1g every 24 hours iv (2-4 min infusion) It depends on strain sensitivity: Strain with resistance to quinolone but sensitivity to cephalosporins

Trial Locations (22)

28034

Hospital Ramón y Cajal, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

30120

Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar

33006

Hospital Universitario Central de Asturias, Oviedo

35010

Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria

38320

Hospital Universitario de Canarias, San Cristóbal de La Laguna

39008

Hospital Marqués de Valdecilla, Santander

41009

Hospital Universitario Virgen Macarena, Seville

46026

Hospital Universitario y Politécnico La Fe, Valencia

50009

Hospital Royo Villanova, Zaragoza

08221

Hospital Mutua de Terrassa, Terrassa

Unknown

Hospital Arnau de Vilanova, Vilanova

Hospital General Universitario de Alicante, Alicante

Hospital Universitario de Bellvitge, Barcelona

Hospital de Cruces, Bilbao

Hospital Universitario Reina Sofía, Córdoba

03010

Hospital Marina Baixa, Alicante

08003

Hospital Parc Salud Mar, Barcelona

08025

Hospital de la Santa Creu i San Pau, Barcelona

08035

Hospital Vall d'Hebron, Barcelona

09006

Hospital Universitario de Burgos, Burgos

07010

Hospital Son Espases, Palma de Mallorca

All Listed Sponsors
collaborator

Spanish Network for Research in Infectious Diseases

OTHER

lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT02142751 - Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli | Biotech Hunter | Biotech Hunter